Portopulmonary hypertension

Seminars in Respiratory and Critical Care Medicine

Volumn 33, Issue 1, 2012, Pages 17-25

  Krowka, Michael J ^a  

^a MAYO CLINIC   (United States)

Author keywords

liver transplant; portal hypertension; portopulmonary hypertension; pulmonary hypertension

Indexed keywords

AMBRISENTAN; BOSENTAN; ENDOTHELIN RECEPTOR ANTAGONIST; ILOPROST; PHOSPHODIESTERASE INHIBITOR; PROSTACYCLIN; PROSTACYCLIN DERIVATIVE; SILDENAFIL; UNIPROST; VASODILATOR AGENT;

CONTINUOUS INFUSION; DISEASE COURSE; DISEASE SEVERITY; HEART CATHETERIZATION; HEART RIGHT VENTRICLE FAILURE; HUMAN; INCIDENCE; LIVER DISEASE; LIVER TRANSPLANTATION; LONG TERM SURVIVAL; LUNG HEMODYNAMICS; LUNG VASCULAR RESISTANCE; PORTAL HYPERTENSION; PORTOPULMONARY HYPERTENSION; PRIORITY JOURNAL; PROGNOSIS; PULMONARY ARTERY OCCLUSION; PULMONARY HYPERTENSION; REVIEW; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; TREATMENT OUTCOME; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; VENOUS CONGESTION;

HUMANS; HYPERTENSION, PORTAL; HYPERTENSION, PULMONARY; LIVER TRANSPLANTATION; VASODILATOR AGENTS;

EID: 84858740438     PISSN: 10693424     EISSN: 10989048     Source Type: Journal    
DOI: 10.1055/s-0032-1301731     Document Type: Review

References (50)

1. Rodrguez-Roisin R, Krowka MJ, Herv P, Fallon MB.; ERS Task Force Pulmonary-Hepatic Vascular Disorders (PHD) Scientific Committee. Pulmonary-hepatic vascular disorders (PHD). Eur Respir J: 2004; 24 5 861 880 (Pubitemid 39504442)
2. Stauber RE, Olschewski H. Portopulmonary hypertension: short review. Eur J Gastroenterol Hepatol: 2010; 22 4 385 390
3. Simonneau G, Robbins IM, Beghetti M., et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol: 2009; 54 1, Suppl S43 S54
4. Krowka MJ, Swanson KL, Frantz RP, McGoon MD, Wiesner RH. Portopulmonary hypertension: results from a 10-year screening algorithm. Hepatology: 2006; 44 6 1502 1510 (Pubitemid 44953655)
5. Hadengue A, Benhayoun MK, Lebrec D, Benhamou JP. Pulmonary hypertension complicating portal hypertension: prevalence and relation to splanchnic hemodynamics. Gastroenterology: 1991; 100 2 520 528
6. Kawut SM, Krowka MJ, Trotter JF., et al. Pulmonary Vascular Complications of Liver Disease Study Group. Clinical risk factors for portopulmonary hypertension. Hepatology: 2008; 48 1 196 203 (Pubitemid 351975544)
7. Ramsay MAE, Simpson BR, Nguyen AT, Ramsay KJ, East C, Klintmalm GB. Severe pulmonary hypertension in liver transplant candidates. Liver Transpl Surg: 1997; 3 5 494 500 (Pubitemid 27427898)
8. Humbert M, Sitbon O, Chaouat A., et al. Pulmonary arterial hypertension in France: results from a national registry. Am J Respir Crit Care Med: 2006; 173 9 1023 1030
9. Krowka MJ, Miller DP, Barst RJ., et al. Portopulmonary hypertension: a report from the US-based REVEAL Registry. In press
10. Condino AA, Ivy DD, O'Connor JA., et al. Portopulmonary hypertension in pediatric patients. J Pediatr: 2005; 147 1 20 26 (Pubitemid 40981140)
11. Whitworth JR, Sokol RJ. Hepato-portopulmonary disordersnot just in adults! J Pediatr Gastroenterol Nutr: 2005; 41 4 393 395
12. Talwaker JA, Swanson KL, Krowka MJ, Andrews JC, Kamath PS. Prevalence of spontaneous portosystemic shunts in patients with portopulmonary hypertension and effect on treatment. Gastroenterology: 2011; 141 5 1673 1679
13. Mantz FA Jr, Craige E. Portal axis thrombosis with spontaneous portacaval shunt and resistant cor pulmonale. AMA Arch Pathol: 1951; 52 401 409
14. Naeye RL. "Primaryo" pulmonary hypertension with coexisting portal hypertension: a retrospective study of six cases. Circulation: 1960; 22 376 384
15. Senior RM, Britton RC, Turino GM, Wood JA, Langer GA, Fishman AP. Pulmonary hypertension associated with cirrhosis of the liver and with portacaval shunts. Circulation: 1968; 37 1 88 96
16. Lebrec D, Capron JP, Dhumeaux D, Benhamou JP. Pulmonary hypertension complicating portal hypertension. Am Rev Respir Dis: 1979; 120 4 849 856 (Pubitemid 10194952)
17. Edwards BS, Weir EK, Edwards WD, Ludwig J, Dykoski RK, Edwards JE. Coexistent pulmonary and portal hypertension: morphologic and clinical features. J Am Coll Cardiol: 1987; 10 6 1233 1238 (Pubitemid 18004673)
18. Sankey EA, Crow J, Mallett SV., et al. Pulmonary platelet aggregates: possible cause of sudden perioperative death in adults undergoing liver transplantation. J Clin Pathol: 1993; 46 3 222 227 (Pubitemid 23098620)
19. Lockhart A. Pulmonary artery hypertension in portal hypertension. Gastroenterology: 1985; 14 123 138
20. Roberts KE, Fallon MB, Krowka MJ., et al. Pulmonary Vascular Complications of Liver Disease Study Group. Genetic risk factors for portopulmonary hypertension in patients with advanced liver disease. Am J Respir Crit Care Med: 2009; 179 9 835 842
21. Tuder RM, Cool CD, Geraci MW., et al. Prostacyclin synthase expression is decreased in lungs from patients with severe pulmonary hypertension. Am J Respir Crit Care Med: 1999; 159 6 1925 1932 (Pubitemid 29275065)
22. Benjaminov FS, Prentice M, Sniderman KW, Siu S, Liu P, Wong F. Portopulmonary hypertension in decompensated cirrhosis with refractory ascites. Gut: 2003; 52 9 1355 1362 (Pubitemid 37026471)
23. Pellicelli AM, Barbaro G, Puoti C., et al. Plasma cytokines and portopulmonary hypertension in patients with cirrhosis waiting for orthotopic liver transplantation. Angiology: 2010; 61 8 802 806
24. Swanson KL, Wiesner RH, Nyberg SL, Rosen CB, Krowka MJ. Survival in portopulmonary hypertension: Mayo Clinic experience categorized by treatment subgroups. Am J Transplant: 2008; 8 11 2445 2453
25. Robalino BD, Moodie DS. Association between primary pulmonary hypertension and portal hypertension: analysis of its pathophysiology and clinical, laboratory and hemodynamic manifestations. J Am Coll Cardiol: 1991; 17 2 492 498
26. Le Pavec J, Souza R, Herve P., et al. Portopulmonary hypertension: survival and prognostic factors. Am J Respir Crit Care Med: 2008; 178 6 637 643
27. Kawut SM, Taichman DB, Ahya VN., et al. Hemodynamics and survival of patients with portopulmonary hypertension. Liver Transpl: 2005; 11 9 1107 1111 (Pubitemid 41341761)
28. Hoeper MM, Seyfarth HJ, Hoeffken G., et al. Experience with inhaled iloprost and bosentan in portopulmonary hypertension. Eur Respir J: 2007; 30 6 1096 1102 (Pubitemid 351194755)
29. Cartin-Ceba R, Swanson KL, Iyer V, Wiesner RH, Krowka MJ. Safety and efficacy of ambrisentan for the treatment of portopulmonary hypertension. Chest: 2011; 139 1 109 114
30. Reichenberger F, Voswinckel R, Steveling E., et al. Sildenafil treatment for portopulmonary hypertension. Eur Respir J: 2006; 28 3 563 567 (Pubitemid 44794671)
31. Hemmes AR, Robbins IM. Sildenafil monotherapy in portopulmonary hypertension can facilitate liver transplantation. Liver Transpl: 2009; 15 1 15 19
32. Gough MS, White RJ. Sildenafil therapy is associated with improved hemodynamics in liver transplantation candidates with pulmonary arterial hypertension. Liver Transpl: 2009; 15 1 30 36
33. Kuo PC, Johnson LB, Plotkin JS, Howell CD, Bartlett ST, Rubin LJ. Continuous intravenous infusion of epoprostenol for the treatment of portopulmonary hypertension. Transplantation: 1997; 63 4 604 606 (Pubitemid 27102632)
34. Krowka MJ, Frantz RP, McGoon MD, Severson C, Plevak DJ, Wiesner RH. Improvement in pulmonary hemodynamics during intravenous epoprostenol (prostacyclin): a study of 15 patients with moderate to severe portopulmonary hypertension. Hepatology: 1999; 30 3 641 648 (Pubitemid 29409407)
35. Sussman N, Kaza V, Barshes N., et al. Successful liver transplantation following medical management of portopulmonary hypertension: a single-center series. Am J Transplant: 2006; 6 9 2177 2182 (Pubitemid 44199553)
36. Ashfaq M, Chinnakotla S, Rogers L., et al. The impact of treatment of portopulmonary hypertension on survival following liver transplantation. Am J Transplant: 2007; 7 5 1258 1264 (Pubitemid 46643089)
37. Fix OK, Bass NM, De Marco T, Merriman RB. Long-term follow-up of portopulmonary hypertension: effect of treatment with epoprostenol. Liver Transpl: 2007; 13 6 875 885 (Pubitemid 46939441)
38. Sakai T, Planinsic RM, Mathier MA, de Vera ME, Venkataramanan R. Initial experience using continuous intravenous treprostinil to manage pulmonary arterial hypertension in patients with end-stage liver disease. Transpl Int: 2009; 22 5 554 561
39. Melgosa MT, Ricci GL, Garca-Pagan JC., et al. Acute and long-term effects of inhaled iloprost in portopulmonary hypertension. Liver Transpl: 2010; 16 3 348 356
40. Krowka MJ, Plevak DJ, Findlay JY, Rosen CB, Wiesner RH, Krom RA. Pulmonary hemodynamics and perioperative cardiopulmonary-related mortality in patients with portopulmonary hypertension undergoing liver transplantation. Liver Transpl: 2000; 6 4 443 450 (Pubitemid 30489117)
41. Krowka MJ, Mandell MS, Ramsay MA., et al. Hepatopulmonary syndrome and portopulmonary hypertension: a report of the multicenter liver transplant database. Liver Transpl: 2004; 10 2 174 182 (Pubitemid 38240114)
42. Murray KF, Carithers RL Jr.; AASLD. AASLD practice guidelines: evaluation of the patient for liver transplantation. Hepatology: 2005; 41 6 1407 1432 (Pubitemid 40770295)
43. Ramsay M. Portopulmonary hypertension and right heart failure in patients with cirrhosis. Curr Opin Anaesthesiol: 2010; 23 2 145 150
44. Fukazawa K, Pretto EA Jr. Poor outcome following aborted orthotopic liver transplantation due to severe porto-pulmonary hypertension. J Hepatobiliary Pancreat Sci: 2010; 17 4 505 508
45. Castro M, Krowka MJ, Schroeder DR., et al. Frequency and clinical implications of increased pulmonary artery pressures in liver transplant patients. Mayo Clin Proc: 1996; 71 6 543 551
46. DePeitri L, Montalti R, Begliomini B., et al. Pulmonary hypertension as a predictor of postoperative complications and mortality after liver transplantation. Transplant Proc: 2010; 42 4 1188 1190
47. Tapper EB, Knowles D, Heffron T, Lawrence EC, Csete M. Portopulmonary hypertension: imatinib as a novel treatment and the Emory experience with this condition. Trans Proc: 2009; 41 5 1969 1971
48. Krowka MJ, Fallon MB, Mulligan DC, Gish RG. Model for end-stage liver disease (MELD) exception for portopulmonary hypertension. Liver Transpl: 2006; 12 Suppl 3 S114 S116 (Pubitemid 44911788)
49. Bandara M, Gordon FD, Sarwar A., et al. Successful outcomes following living donor liver transplantation for portopulmonary hypertension. Liver Transpl: 2010; 16 8 983 989
50. Koch DG, Caplan M, Reuben A. Pulmonary hypertension after liver transplantation: case presentation and review of the literature. Liver Transpl: 2009; 15 4 407 412